Journal of Thrombosis and Thrombolysis

Papers
(The H4-Index of Journal of Thrombosis and Thrombolysis is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
COVID-19 update: Covid-19-associated coagulopathy474
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum316
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2229
COVID-19-associated vasculitis and vasculopathy208
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature187
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors180
Neutrophil extracellular traps and thrombosis in COVID-19173
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia152
Heparin resistance in COVID-19 patients in the intensive care unit129
The association between treatment with heparin and survival in patients with Covid-19126
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients117
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis109
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis81
Anticipating the long-term cardiovascular effects of COVID-1979
Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-1973
COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness67
Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report65
Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients64
Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis64
High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?61
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy60
Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-1958
DVT incidence and risk factors in critically ill patients with COVID-1958
Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review57
Anticoagulant treatment in COVID-19: a narrative review56
Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients52
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE51
Risk factors for intracerebral hemorrhage in patients with COVID-1947
Covid-19 treatment update: follow the scientific evidence42
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-1940
COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis39
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis38
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-1938
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?38
Incidence of thrombotic complications in COVID-1937
In vivo demonstration of microvascular thrombosis in severe COVID-1936
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor’s page series36
Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-1936
0.095931053161621